# Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice

Source: [Nanotechnology News - Nanoscience, Nanotechnolgy, Nanotech News](https://phys.org/news/2026-11-stem-cellderived-nanoparticles-modulate-immune.html) · 2026-11-18 · Physics
Page: https://themorning.science/story/stem-cell-derived-nanoparticles-modulate-immune-cells-and-help-delay-type-1-diab-c263614471f4efa7
Kind: research · Impact: medium

## In brief

- In type 1 diabetes, the immune system attacks insulin-producing cells in the pancreas.
- Insulin therapy helps manage the disease but does not stop the underlying immune attack.
- Stem cell-derived nanoparticles were reported to modulate immune cells and help delay type 1 diabetes in mice.

## Why it matters

The work targets the immune attack behind type 1 diabetes rather than only blood sugar management, but the sources report results in mice only, so relevance to people is not yet established.

## Coverage

- [Stem cell–derived nanoparticles modulate immune cells and help delay type 1 diabetes in mice](https://phys.org/news/2026-11-stem-cellderived-nanoparticles-modulate-immune.html) — Nanotechnology News - Nanoscience, Nanotechnolgy, Nanotech News, 2026-11-18

Tags: type 1 diabetes, nanoparticles, stem cells, immunology, mice

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
